Tate & Lyle Expands BioHarvest Deal to Develop Plant Cell-Cultivated Sweetener Range
Ingredient solutions company Tate & Lyle and Canadian biotech firm BioHarvest Sciences have expanded their joint development program to cover a broader range of plant-based sweetener molecules, building on an initial agreement signed in 2024. The enlarged program draws on BioHarvest’s Botanical Synthesis platform, a non-GMO industrial plant cell culture technology that produces plant-derived compounds without cultivating the whole plant, reducing dependence on conventional agricultural extraction for botanicals that are …